KRAS-IFLTD1 Fusion FISH Probe
The KRAS-IFLTD1 Fusion FISH Probe is used to confirm a fusion of the KRAS and IFLTD1 genes. The fusion of the KRAS and IFLTD1 genes has been associated with Ovarian Serous Cystadenocarcinoma. These probes are FISH confirmed on normal peripheral blood in both interphase nuclei and metaphase spreads before shipment. Typical turnaround time for this product is 7-14 days after purchase.
** This product is for in vitro and research use only. This product is not intended for diagnostic use. Please note that both genes fall on the same chromosome and inter-chromosomal detection may be difficult to detect depending on the genes proximity to one another. Please consult our support staff before ordering this product to ensure that the probe can be designed to meet your specific needs.
| SKU | Test Kits | Buffer | Dye Color | Order Now |
|---|---|---|---|---|
| KRAS-IFLTD1-20-ORGR (Standard Design) | 20 (40 μL) | 200 μL |
|
|
| KRAS-IFLTD1-20-RERE | 20 (40 μL) | 200 μL |
|
|
| KRAS-IFLTD1-20-REOR | 20 (40 μL) | 200 μL |
|
|
| KRAS-IFLTD1-20-REGO | 20 (40 μL) | 200 μL |
|
|
| KRAS-IFLTD1-20-REGR | 20 (40 μL) | 200 μL |
|
|
| KRAS-IFLTD1-20-REAQ | 20 (40 μL) | 200 μL |
|
|
| KRAS-IFLTD1-20-ORRE | 20 (40 μL) | 200 μL |
|
|
| KRAS-IFLTD1-20-OROR | 20 (40 μL) | 200 μL |
|
|
| KRAS-IFLTD1-20-ORGO | 20 (40 μL) | 200 μL |
|
|
| KRAS-IFLTD1-20-ORAQ | 20 (40 μL) | 200 μL |
|
|
| KRAS-IFLTD1-20-GORE | 20 (40 μL) | 200 μL |
|
|
| KRAS-IFLTD1-20-GOOR | 20 (40 μL) | 200 μL |
|
|
| KRAS-IFLTD1-20-GOGO | 20 (40 μL) | 200 μL |
|
|
| KRAS-IFLTD1-20-GOGR | 20 (40 μL) | 200 μL |
|
|
| KRAS-IFLTD1-20-GOAQ | 20 (40 μL) | 200 μL |
|
|
| KRAS-IFLTD1-20-GRRE | 20 (40 μL) | 200 μL |
|
|
| KRAS-IFLTD1-20-GROR | 20 (40 μL) | 200 μL |
|
|
| KRAS-IFLTD1-20-GRGO | 20 (40 μL) | 200 μL |
|
|
| KRAS-IFLTD1-20-GRGR | 20 (40 μL) | 200 μL |
|
|
| KRAS-IFLTD1-20-GRAQ | 20 (40 μL) | 200 μL |
|
|
| KRAS-IFLTD1-20-AQRE | 20 (40 μL) | 200 μL |
|
|
| KRAS-IFLTD1-20-AQOR | 20 (40 μL) | 200 μL |
|
|
| KRAS-IFLTD1-20-AQGO | 20 (40 μL) | 200 μL |
|
|
| KRAS-IFLTD1-20-AQGR | 20 (40 μL) | 200 μL |
|
|
| KRAS-IFLTD1-20-AQAQ | 20 (40 μL) | 200 μL |
|
KRAS Gene Summary
This gene, a Kirsten ras oncogene homolog from the mammalian ras gene family, encodes a protein that is a member of the small GTPase superfamily. A single amino acid substitution is responsible for an activating mutation. The transforming protein that results is implicated in various malignancies, including lung adenocarcinoma, mucinous adenoma, ductal carcinoma of the pancreas and colorectal carcinoma. Alternative splicing leads to variants encoding two isoforms that differ in the C-terminal region. [provided by RefSeq, Jul 2008]
Gene Name: KRAS Proto-oncogene, GTPase
Chromosome: CHR12: 25358179 -25403854
Locus: 12p12.1
Gene Diseases
The KRAS IFLTD1 Fusion has been associated with the following diseases:
| Disease Name |
|---|
| Ovarian Serous Cystadenocarcinoma |
FISH Probe Protocols
| Protocol, Procedure, or Form Name | Last Modified | Download |
|---|